Advisory Services Network, LLC Sorrento Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.74 - $1.83 $658 - $1,628	890 New	890 $0
Q2 2022 Aug 02, 2022	SELL	$1.24 - $2.33 $30,764 - $57,807	-24,810 Closed	0 $0
Q1 2022 May 23, 2022	BUY	$2.0 - $4.9 $49,620 - $121,569	24,810 New	24,810 $58,000
Q1 2021 May 24, 2021	SELL	$7.03 - $16.51 $8,000 - $18,788	-1,138 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$5.76 - $11.95 $4,112 - $8,532	714 Added 168.4%	1,138 $8,000
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $2,616 - $7,979	424 New	424 $5,000
Q1 2020 May 15, 2020	SELL	$1.57 - $4.76 $15,700 - $47,600	-10,000 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.45 - $4.17 $14,500 - $41,700	10,000 New	10,000 $34,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.